EC Number | Cloned (Comment) | Organism |
---|---|---|
2.1.1.20 | - |
Homo sapiens |
2.1.1.20 | - |
Rattus norvegicus |
2.1.1.20 | - |
Oryctolagus cuniculus |
2.1.1.20 | - |
Mus musculus |
2.1.1.20 | - |
Sus scrofa |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.1.1.20 | - |
Rattus norvegicus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.1.1.20 | H176N | the mutant activity decreases 25% regarding Vmax | Homo sapiens |
2.1.1.20 | L149P | the mutant is inactivated by 90% | Homo sapiens |
2.1.1.20 | N140S | the mutant possesses only traces of wild type activity | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.20 | 5-methyl-tetrahydrofolate | - |
Homo sapiens | |
2.1.1.20 | 5-methyl-tetrahydrofolate | - |
Mus musculus | |
2.1.1.20 | 5-methyl-tetrahydrofolate | - |
Oryctolagus cuniculus | |
2.1.1.20 | 5-methyl-tetrahydrofolate | - |
Rattus norvegicus | |
2.1.1.20 | 5-methyl-tetrahydrofolate | - |
Sus scrofa | |
2.1.1.20 | 5-Methyltetrahydrofolate pentaglutamate | noncompetitive inhibitor with respect to substrates S-adenosyl-L-methionine and glycine | Homo sapiens | |
2.1.1.20 | 5-Methyltetrahydrofolate pentaglutamate | noncompetitive inhibitor regarding substrates S-adenosyl-L-methionine and glycine | Mus musculus | |
2.1.1.20 | 5-Methyltetrahydrofolate pentaglutamate | noncompetitive inhibitor with respect to substrates S-adenosyl-L-methionine and glycine | Oryctolagus cuniculus | |
2.1.1.20 | 5-Methyltetrahydrofolate pentaglutamate | noncompetitive inhibitor with respect to substrates S-adenosyl-L-methionine and glycine | Rattus norvegicus | |
2.1.1.20 | 5-Methyltetrahydrofolate pentaglutamate | noncompetitive inhibitor with respect to substrates S-adenosyl-L-methionine and glycine | Sus scrofa |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.1.1.20 | cytosol | - |
Homo sapiens | 5829 | - |
2.1.1.20 | cytosol | - |
Rattus norvegicus | 5829 | - |
2.1.1.20 | cytosol | - |
Oryctolagus cuniculus | 5829 | - |
2.1.1.20 | cytosol | - |
Mus musculus | 5829 | - |
2.1.1.20 | cytosol | - |
Sus scrofa | 5829 | - |
2.1.1.20 | nucleus | - |
Homo sapiens | 5634 | - |
2.1.1.20 | nucleus | - |
Rattus norvegicus | 5634 | - |
2.1.1.20 | nucleus | - |
Oryctolagus cuniculus | 5634 | - |
2.1.1.20 | nucleus | - |
Mus musculus | 5634 | - |
2.1.1.20 | nucleus | - |
Sus scrofa | 5634 | - |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.1.1.20 | 32500 | - |
4 * 32500 | Homo sapiens |
2.1.1.20 | 32500 | - |
4 * 32500 | Rattus norvegicus |
2.1.1.20 | 32500 | - |
4 * 32500 | Oryctolagus cuniculus |
2.1.1.20 | 32500 | - |
4 * 32500 | Mus musculus |
2.1.1.20 | 32500 | - |
4 * 32500 | Sus scrofa |
2.1.1.20 | 130000 | - |
- |
Homo sapiens |
2.1.1.20 | 130000 | - |
- |
Rattus norvegicus |
2.1.1.20 | 130000 | - |
- |
Oryctolagus cuniculus |
2.1.1.20 | 130000 | - |
- |
Mus musculus |
2.1.1.20 | 130000 | - |
- |
Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.20 | Homo sapiens | - |
- |
- |
2.1.1.20 | Mus musculus | Q9QXF8 | - |
- |
2.1.1.20 | Oryctolagus cuniculus | - |
- |
- |
2.1.1.20 | Rattus norvegicus | - |
- |
- |
2.1.1.20 | Sus scrofa | Q29555 | - |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
2.1.1.20 | phosphoprotein | GNMT is phosphorylated by cAMP-dependent protein kinase at Ser9, Ser71, Ser139, Ser182, and Ser241 | Homo sapiens |
2.1.1.20 | phosphoprotein | GNMT is phosphorylated by cAMP-dependent protein kinase at Ser9, Ser71, Ser139, Ser182, and Ser241 | Rattus norvegicus |
2.1.1.20 | phosphoprotein | GNMT is phosphorylated by cAMP-dependent protein kinase at Ser9, Ser71, Ser139, Ser182, and Ser241 | Oryctolagus cuniculus |
2.1.1.20 | phosphoprotein | GNMT is phosphorylated by cAMP-dependent protein kinase at Ser9, Ser71, Ser139, Ser182, and Ser241 | Sus scrofa |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.1.1.20 | - |
Homo sapiens |
2.1.1.20 | - |
Rattus norvegicus |
2.1.1.20 | - |
Oryctolagus cuniculus |
2.1.1.20 | - |
Mus musculus |
2.1.1.20 | - |
Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.20 | hepatocellular carcinoma cell | - |
Homo sapiens | - |
2.1.1.20 | hepatocellular carcinoma cell | - |
Mus musculus | - |
2.1.1.20 | kidney | - |
Homo sapiens | - |
2.1.1.20 | kidney | - |
Rattus norvegicus | - |
2.1.1.20 | kidney | - |
Mus musculus | - |
2.1.1.20 | kidney | - |
Sus scrofa | - |
2.1.1.20 | liver | - |
Homo sapiens | - |
2.1.1.20 | liver | - |
Rattus norvegicus | - |
2.1.1.20 | liver | - |
Oryctolagus cuniculus | - |
2.1.1.20 | liver | - |
Mus musculus | - |
2.1.1.20 | liver | - |
Sus scrofa | - |
2.1.1.20 | additional information | no GNMT activity is detected in fetal liver, Novikoff hepatoma cells, Morris hepatoma cells, and Ehrlich ascites cells | Homo sapiens | - |
2.1.1.20 | additional information | no GNMT activity is detected in fetal liver, Novikoff hepatoma cells, Morris hepatoma cells, and Ehrlich ascites cells | Mus musculus | - |
2.1.1.20 | pancreas | - |
Homo sapiens | - |
2.1.1.20 | pancreas | - |
Rattus norvegicus | - |
2.1.1.20 | pancreas | - |
Mus musculus | - |
2.1.1.20 | pancreas | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.20 | additional information | GNMT is phosphorylated by cAMP-dependent protein kinase at Ser9, Ser71, Ser139, Ser182, and Ser241 | Mus musculus | ? | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Homo sapiens | S-adenosyl-L-homocysteine + N-methylglycine | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Rattus norvegicus | S-adenosyl-L-homocysteine + N-methylglycine | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Oryctolagus cuniculus | S-adenosyl-L-homocysteine + N-methylglycine | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Mus musculus | S-adenosyl-L-homocysteine + N-methylglycine | - |
? | |
2.1.1.20 | S-adenosyl-L-methionine + glycine | - |
Sus scrofa | S-adenosyl-L-homocysteine + N-methylglycine | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.1.1.20 | homotetramer | 4 * 32500 | Homo sapiens |
2.1.1.20 | homotetramer | 4 * 32500 | Rattus norvegicus |
2.1.1.20 | homotetramer | 4 * 32500 | Oryctolagus cuniculus |
2.1.1.20 | homotetramer | 4 * 32500 | Mus musculus |
2.1.1.20 | homotetramer | 4 * 32500 | Sus scrofa |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.20 | GNMT | - |
Homo sapiens |
2.1.1.20 | GNMT | - |
Rattus norvegicus |
2.1.1.20 | GNMT | - |
Oryctolagus cuniculus |
2.1.1.20 | GNMT | - |
Mus musculus |
2.1.1.20 | GNMT | - |
Sus scrofa |
EC Number | Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|---|
2.1.1.20 | Rattus norvegicus | - |
- |
6.4 |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.1.1.20 | 0.001 | - |
at pH 9.0 | Rattus norvegicus | 5-Methyltetrahydrofolate pentaglutamate | |
2.1.1.20 | 0.002 | - |
at pH 7.5 | Rattus norvegicus | 5-Methyltetrahydrofolate pentaglutamate |